Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
Radiological biomarkers have been reported for multiple system atrophy and progressive supranuclear palsy, but serum/plasma biomarkers for each disorder have not been established. In this context, we performed a pilot study to identify disease-specific plasma biomarkers for multiple system atrophy a...
Main Authors: | Akio Mori, Kei-Ichi Ishikawa, Shinji Saiki, Taku Hatano, Yutaka Oji, Ayami Okuzumi, Motoki Fujimaki, Takahiro Koinuma, Shin-Ichi Ueno, Yoko Imamichi, Nobutaka Hattori |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223113 |
Similar Items
-
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
by: Shinji Saiki, et al.
Published: (2017-08-01) -
Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
by: Shin‐Ichi Ueno, et al.
Published: (2020-03-01) -
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
by: Shin-Ichi Ueno, et al.
Published: (2018-12-01) -
Metabolomic analysis data of MPP+-exposed SH-SY5Y cells using CE-TOFMS
by: Taku Amo, et al.
Published: (2021-02-01) -
Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy
by: Jesse A. Brown, et al.
Published: (2017-01-01)